Mark Simon, Director at Cabaletta Bio, Inc. (CABA), bought 125,000 shares at $0.98 ($123K) on 2022-10-18, disclosed to the SEC on 2022-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.98 | 7,000 | $7K | 5.6% |
| 2 | $0.98 | 118,000 | $116K | 94.4% |
| Total | $0.98 avg | 125,000 | $123K | 100% |